Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a revision note: Revision: v3.4.2 replacing v3.4.1. This is a cosmetic update and does not affect the study details or how a user interacts with the page.SummaryDifference0.1%

- Check20 days agoChange DetectedFooter revision tag updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary toggle added and footer wording updated to 'No FEAR Act Data' with revision 3.4.0; previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 3.3.4 were replaced.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Wisconsin as a study location; updated page revision from v3.3.2 to v3.3.3, removing the previous Wisconsin Locations entry and HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision: v3.3.2 is now shown in the page footer, replacing Revision: v3.2.0. There are no significant changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.